A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)
Sign Up to like & getrecommendations! Published in 2020 at "Drug Safety"
DOI: 10.1007/s40264-020-00928-1
Abstract: Lurasidone is a second-generation antipsychotic used in the treatment of schizophrenia and bipolar disorder [1]. An analysis to identify adverse drug events (ADEs) associated with lurasidone in children is lacking. The aim of this investigation… read more here.
Keywords: reporting; associated lurasidone; drug; drug events ... See more keywords
A Case of Hypersexuality Probably Associated With Lurasidone.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001272
Abstract: brain activity – a state resembling the kappa opioid receptor electroencephalographic profile. These mechanisms are ostensibly induced to mitigate drug-induced neurotoxicity. Problematically, though, chronic dynorphin/kappa opioid receptor activation is thought to undergird a plethora of… read more here.
Keywords: case hypersexuality; treatment; associated lurasidone; hypersexuality probably ... See more keywords